elmundo.es
Understanding and Managing Non-Alcoholic Fatty Liver Disease
This article discusses non-alcoholic fatty liver disease (NAFLD), its prevalence, diagnosis, treatment, and long-term health risks. It highlights the importance of lifestyle modifications and early detection.
Spanish
Spain
HealthLifestyleObesityDiabetesCardiovascular DiseaseMetabolic HealthLiver Disease
Policlínico De MilánUniversidad De Milán
Anna Ludovica FracanzaniLuigi Ripamonti
- How is NAFLD diagnosed, and what tests are typically used?
- Diagnosis involves blood tests to check liver enzyme levels (transaminases) and an ultrasound to visualize the liver. Further tests like Fibroscan may be used to assess fibrosis, and a carotid Doppler ultrasound might be done to check for cardiovascular risks.
- What are the common symptoms and risk factors associated with NAFLD?
- NAFLD is frequently asymptomatic in its early stages, making early detection crucial. Risk factors include obesity, hypertension, high triglycerides, and diabetes; regular checkups and blood tests are vital for early identification.
- What are the potential long-term health consequences of untreated NAFLD?
- While NAFLD was once considered benign, it is now recognized as a serious condition that can increase the risk of developing type 2 diabetes, cardiovascular diseases, and even liver cancer. Fortunately, lifestyle changes and medical treatment can often reverse the condition or significantly reduce its progression.
- What is non-alcoholic fatty liver disease (NAFLD), and how prevalent is it?
- Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition affecting 25-33% of adults, often linked to metabolic syndrome. It's characterized by fat accumulation in the liver, potentially leading to inflammation, fibrosis, and even liver cancer.
- What are the recommended treatments and lifestyle modifications for managing NAFLD?
- Treatment for NAFLD focuses on lifestyle modifications: weight loss (if needed), adopting a Mediterranean-style diet, and regular physical activity. Pharmacological interventions may be considered for managing related cardiovascular risk factors like high blood pressure and diabetes.